Patient Square Capital and Premji Invest co-led the $320m Seris D funding round in Kriya.

Patient Square Capital and Premji Invest, both private equity firms, co-led the $320m Series D funding round in Kriya, a biotechnology company developing gene therapies for chronic diseases of high unmet need, with participation from Peter Thiel, Narya Capital, and The T1D Fund.